Research Paper Volume 13, Issue 6 pp 8688—8705
Establishment and validation of an eight-gene metabolic–related prognostic signature model for lung adenocarcinoma
Figure 2. The relationship between the ESTIMATE score and clinical status, survival outcomes. (A–G) Boxplot showing the difference between the ESTIMATE score and the clinical characteristic. p value above the boxplot indicates the difference between the two groups. (H–I) The Kaplan–Meier curves for overall survival and progression free survival of LUAD risk groups divided using the median cutoff point of ESTIMATE score.